C12N 2770/14041
Use of virus, viral particle or viral elements as a vector
C12N2770/14041 (Use of virus, viral particle or viral elements as a vector) appears on 7 US grants and 20 published applications in this corpus.
Search patents in C12N- Granted patents
- 7
- Published applications
- 20
- Assignees
- 16
- Inventors
- 43
- Latest grant
- 4 Apr 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2011 | 0 | 2 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 1 | 1 |
| 2016 | 0 | 0 |
| 2017 | 1 | 1 |
| 2018 | 0 | 0 |
| 2019 | 1 | 1 |
| 2020 | 0 | 2 |
| 2021 | 3 | 1 |
| 2022 | 0 | 2 |
| 2023 | 1 | 2 |
| 2024 | 0 | 1 |
| 2025 | 0 | 3 |
| 2026 | 0 | 3 |
By publication year. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12N 2770/14042Virus or viral particle as vehicleIndexing code6
- C12N 2770/14043Viral genome or elements thereof as genetic vectorIndexing code1
- C12N 2770/14044Chimeric viral vector comprising heterologous viral elements for production of another viralIndexing code0
- C12N 2770/14045Special targeting system for viral vectorsIndexing code0
Recent patents
- Covalently fused viral coat proteins for the display of target molecules4 Apr 2023US 11,618,771 B2Fraunhofer USA, Inc.
- Virus-enabled targeted vector for imaging21 Dec 2021US 11,202,841 B2The Trustees of Indiana University
- Covalently fused viral coat proteins for the display of target molecules3 Aug 2021US 11,078,240 B2Fraunhofer USA, Inc.
- Treatment of peanut allergy26 Jan 2021US 10,898,569 B2Allergy Therapeutics (UK) Limited
- In vitro reconstituted plant virus capsids for delivering RNA genes to mammalian cells5 Mar 2019US 10,221,399 B2The Regents of the University of California
- Compounds for rna stabilisation and delivery23 Jul 2026US 2026/0209277 A1Stichting VU
- Veterinary compositions of modified virus-like particles of cmv and ngf antigens12 Mar 2026US 2026/0069668 A1
- Modified virus-like particles of cmv26 Feb 2026US 2026/0055428 A1Saiba Animal Health AG
- Active vaccination for the treatment of ngf-related disorders11 Sep 2025US 2025/0281584 A1Boehringer Ingelheim Vetmedica GmbH
- Advanced recombinant vector based on cucumber mosaic virus19 Jun 2025US 2025/0197877 A1Kt&G Corporation
Most cited
By later US patents